© 1999 Evidence-Based Mental Health
Eptastigmine led to cognitive, clinical, and functional benefits in Alzheimer's disease
Imbimbo BP, Martelli P, Troetel WM, et al, and the Eptastigmine Study Group. Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease. Neurology 1999 Mar 10;52:700–8.
Question In patients with moderate to moderately severe Alzheimer's disease (AD), how effective and safe is eptastigmine?
Randomised, double blind, placebo controlled trial with 24 weeks of follow up.
36 centres in the US and Europe.
491 patients (mean age 71 y, 63% women) who met the diagnostic criteria for AD established by the NINCDS-ADRDA and described by DSM-IV, and who had a cognitive deficit for 
6 months, a Mini-Mental State Examination Scale score between 10 and 22, a Global Deterioration Scale rating of 4 or 5, a modified Hachinski ischaemic score <3, and a Hamilton Depression Scale score <18. Exclusion criteria were other neurological or psychiatric disorders; renal, hepatic, or cardiovascular diseases; peptic ulcer; bronchial asthma; neutropenia; deficiencies in thyroxine, vitamin B12, or folate; or treatment with medication known to affect the central nervous system. 86% completed the study.
164 patients were assigned to placebo, 166 to 15 mg 3 times daily of eptastigmine, and 161 to 20 mg 3 times daily of eptastigmine
St George's Hospital Medical School London, UK
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Services
- Email this link to a friend
- Similar articles in this journal
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Neurology
-
Dementia, Alzheimer's type
-
Psychiatry of old age
-
Epidemiology
- Clinical trials (epidemiology)
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
